These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 22286996)

  • 21. Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice.
    Craven N; Anderson JC
    Am J Vet Res; 1983 Apr; 44(4):709-12. PubMed ID: 6553464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice.
    Kerr DE; Plaut K; Bramley AJ; Williamson CM; Lax AJ; Moore K; Wells KD; Wall RJ
    Nat Biotechnol; 2001 Jan; 19(1):66-70. PubMed ID: 11135555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective Treatment of
    Brouillette E; Millette G; Chamberland S; Roy JP; Ster C; Kiros T; Hickey S; Hittle L; Woolston J; Malouin F
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112867
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan.
    Sundarrajan S; Raghupatil J; Vipra A; Narasimhaswamy N; Saravanan S; Appaiah C; Poonacha N; Desai S; Nair S; Bhatt RN; Roy P; Chikkamadaiah R; Durgaiah M; Sriram B; Padmanabhan S; Sharma U
    Microbiology (Reading); 2014 Oct; 160(Pt 10):2157-2169. PubMed ID: 25023246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K.
    Sanz-Gaitero M; Keary R; Garcia-Doval C; Coffey A; van Raaij MJ
    Virol J; 2014 Jul; 11():133. PubMed ID: 25064136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary Gland Pathology Subsequent to Acute Infection with Strong versus Weak Biofilm Forming Staphylococcus aureus Bovine Mastitis Isolates: A Pilot Study Using Non-Invasive Mouse Mastitis Model.
    Gogoi-Tiwari J; Williams V; Waryah CB; Costantino P; Al-Salami H; Mathavan S; Wells K; Tiwari HK; Hegde N; Isloor S; Al-Sallami H; Mukkur T
    PLoS One; 2017; 12(1):e0170668. PubMed ID: 28129375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance.
    Rodríguez-Rubio L; Martínez B; Rodríguez A; Donovan DM; Götz F; García P
    PLoS One; 2013; 8(5):e64671. PubMed ID: 23724076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically enhanced cows resist intramammary Staphylococcus aureus infection.
    Wall RJ; Powell AM; Paape MJ; Kerr DE; Bannerman DD; Pursel VG; Wells KD; Talbot N; Hawk HW
    Nat Biotechnol; 2005 Apr; 23(4):445-51. PubMed ID: 15806099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage-derived endolysins as innovative antimicrobials against bovine mastitis-causing streptococci and staphylococci: a state-of-the-art review.
    Vander Elst N
    Acta Vet Scand; 2024 May; 66(1):20. PubMed ID: 38769566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced killing of penicillin-treated S. aureus by host defences: effects of amoxycillin, cloxacillin and nafcillin in vitro and in experimental mastitis.
    Craven N; Williams MR; Anderson JC
    Comp Immunol Microbiol Infect Dis; 1982; 5(4):447-56. PubMed ID: 6890889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5.
    Rodríguez-Rubio L; Martínez B; Rodríguez A; Donovan DM; García P
    Appl Environ Microbiol; 2012 Apr; 78(7):2241-8. PubMed ID: 22267667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiology and antimicrobial susceptibility of udder pathogens from cases of subclinical mastitis in dairy cows in Sweden.
    Persson Y; Nyman AK; Grönlund-Andersson U
    Acta Vet Scand; 2011 Jun; 53(1):36. PubMed ID: 21649936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b.
    Gonzalez-Delgado LS; Walters-Morgan H; Salamaga B; Robertson AJ; Hounslow AM; Jagielska E; Sabała I; Williamson MP; Lovering AL; Mesnage S
    Nat Chem Biol; 2020 Jan; 16(1):24-30. PubMed ID: 31686030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle.
    Gill JJ; Pacan JC; Carson ME; Leslie KE; Griffiths MW; Sabour PM
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2912-8. PubMed ID: 16940081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.
    Osipovitch DC; Griswold KE
    FEMS Microbiol Lett; 2015 Jan; 362(2):1-7. PubMed ID: 25670705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial drug susceptibility of Staphylococcus aureus strains isolated from bovine and ovine mammary glands.
    Pengov A; Ceru S
    J Dairy Sci; 2003 Oct; 86(10):3157-63. PubMed ID: 14594234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short communication: Antimicrobial efficacy of intramammary treatment with a novel biphenomycin compound against Staphylococcus aureus, Streptococcus uberis, and Escherichia coli-induced mouse mastitis.
    Demon D; Breyne K; Schiffer G; Meyer E
    J Dairy Sci; 2013; 96(11):7082-7087. PubMed ID: 24054294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Employment of mastoparan-like peptides to prevent
    Orozco RMQ; Oshiro KGN; Pinto IB; Buccini DF; Almeida CV; Marin VN; de Souza CM; Macedo MLR; Cardoso MH; Franco OL
    J Bacteriol; 2024 May; 206(5):e0007124. PubMed ID: 38629875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of lysostaphin and a Listeria monocytogenes bacteriophage endolysin produced and secreted by lactic acid bacteria.
    Turner MS; Waldherr F; Loessner MJ; Giffard PM
    Syst Appl Microbiol; 2007 Jan; 30(1):58-67. PubMed ID: 16490333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.